
“Madrigal Pharmaceuticals Gets ‘Buy’ Recommendation from H.C. Wainwright”
21/11/2025
Comments (0)
H.C. Wainwright upgrades Madrigal Pharmaceuticals to a "Buy" rating, highlighting its confidence in the biopharmaceutical company's growth trajectory. The upgrade, bolstered by strategic moves at Madrigal, may spur further investor interest in the stock, indicating promising investment potential in the biopharmaceutical sector. Read more
Read More
“Walmart (WMT) Earns Upbeat Assessment from Truist, New Price Target Set”
20/11/2025
Comments (0)
Truist Financial's new bullish price target for Walmart Inc. places the retail giant at $119 per share—an 11.23% surge. This reflects Walmart's steady Q3 FY2026 performance, with a 6% revenue increase and e-commerce sales growing by 27% globally. Amidst challenging retail dynamics, Walmart positions itself strongly in the digital market, continuing its dominance. Read more
Read More
“Data Storage Corp’s Finance Performance & Strategic Shift”
19/11/2025
Comments (0)
Data Storage Corporation (DTST) beats earnings estimates with a robust EPS and heightened revenue figures, showcasing successful sales strategies and financial health. By shifting focus to high-growth sectors like AI and cybersecurity, DTST enhances its potential for future returns and long-term sustainability. Read more
Read More